Treatment for relapsed or refractory chronic lymphocytic leukaemia: an ongoing challenge

被引：1
|
作者：
Strati, Paolo [1 ]
机构：
[1] Univ Texas Houston, MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
来源：
LANCET HAEMATOLOGY | 2017年 / 4卷 / 03期
关键词：
IDELALISIB; FLUDARABINE; RITUXIMAB;
D O I：
10.1016/S2352-3026(17)30020-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E97 / E98
页数：2
相关论文
共 50 条
  • [21] Cost-utility analysis of idelalisib in combination with rituximab in relapsed or refractory chronic lymphocytic leukaemia
    Felipe Casado, Luis
    Angel Hernandez, Jose
    Jarque, Isidro
    Echave, Maria
    Angel Casado, Miguel
    Castro, Antonio
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (03) : 264 - 272
  • [22] ANALYSIS OF TREATMENT OPTIONS FOR RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Sallum, R.
    Dorman, E.
    Xu, Y.
    Tran-Kerr, K.
    O'Donnell, M.
    Sorensen, S.
    Szatkowski, A.
    Sengupta, N.
    Gaudig, M.
    VALUE IN HEALTH, 2014, 17 (07) : A616 - A616
  • [23] Preclinical evaluation of mosunetuzumab for the treatment of relapsed/refractory chronic lymphocytic leukemia
    Barrett, Kathy
    Lu, Kai
    Jin, Hyun Yong
    Millen, Rosie
    Lefebure, Marcus
    Jiang, Yanwen
    CANCER RESEARCH, 2023, 83 (07)
  • [24] Management of relapsed/refractory Chronic Lymphocytic Leukemia
    Woyach, Jennifer A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S11 - S18
  • [25] Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
    Odetola, Oluwatobi
    Ma, Shuo
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (05) : 130 - 143
  • [26] Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
    Oluwatobi Odetola
    Shuo Ma
    Current Hematologic Malignancy Reports, 2023, 18 : 130 - 143
  • [27] Pharmacotherapy of relapsed/refractory chronic lymphocytic leukemia
    Abou Zahr, Abdallah
    Bose, Prithviraj
    Keating, Michael J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (09) : 857 - 873
  • [28] Management of relapsed/refractory chronic lymphocytic leukemia
    Tomowiak, Cecile
    HEMATOLOGIE, 2024, 30 : 19 - 27
  • [29] PATIENT EXPERIENCE OF SECOND-LINE TREATMENT FOR RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA IN UK CLINICAL PRACTICE: STUDY METHODOLOGY
    El-Sharkawi, D.
    Kelly, J.
    Kent, T.
    Powell, L.
    Martins, D.
    Manzoor, B.
    Evans, E.
    McCarrier, K.
    Johnston, C.
    VALUE IN HEALTH, 2023, 26 (12) : S474 - S474
  • [30] Current Treatment Options in Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: a Review
    Islam, Prioty
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (09) : 1259 - 1273
12345